Real Estate Insiders Deploy $980K Contrarian Bet as Housing Data Surges While Tech Selloff Triggers $3.2M Cross-Sector Value Hunt

3 sources

Real estate finance executives deployed $980K in coordinated buying as August home sales jumped 15.4% YoY to 800K units, beating estimates by 22%. Meanwhile, AI tech selloff sparked $3.2M insider accumulation across beaten-down biotech and specialty finance sectors.

Https://www.howardcountymd.gov/News092325 image related to: real estate insiders deploy 980k contrarian bet as housing data surges while tech selloff triggers 32m cross-sector value hunt

Source: https://www.howardcountymd.gov/News092325

Market Context: Housing Strength Drives Sector Rotation as Tech Valuations Reset

U.S. markets ended Thursday's session mixed as August new home sales exploded 15.4% year-over-year to 800,000 units, crushing the 655,000 consensus estimate and triggering the strongest housing print in months. The surprise data sparked immediate sector rotation as real estate finance insiders deployed $980,000 in coordinated buying while AI heavyweight selling accelerated with Nvidia (-0.8%), Oracle (-1.7%), and Micron (-2.8%) leading tech declines.

The S&P 500 fell 0.2% to 6,637.97 despite energy sector strength (+1.3%) as investors digested a robust jobs report that sent initial jobless claims to multi-month lows. Fed officials' hawkish commentary throughout the session reinforced Powell's September 23rd warning that equity valuations remain "highly overvalued," pressuring growth stocks while value-oriented insiders seized on sector dislocations.

Insider Intelligence: Real Estate Finance Chiefs Signal Recovery Bottom

Nexpoint REIT Leadership Doubles Down on CRE Recovery

NexPoint Real Estate Finance (NREF) President James Dondero deployed the session's largest individual bet, purchasing 66,000 shares at $14.33 for $945,780 on Monday—a massive vote of confidence in commercial real estate lending just as today's housing data validated his thesis. Dondero, who controls over 6.5 million shares, timed his buy precisely as mortgage REITs faced Fed-induced headwinds.

This appears opportunistic rather than scheduled, given NREF's sensitivity to interest rate policy and today's housing surge providing immediate validation. The trade signals Dondero expects CRE fundamentals to outweigh rate concerns as property markets stabilize.

Prospect Capital CEO's Million-Dollar Value Play

Prospect Capital (PSEC) CEO Barry John F executed an even bolder contrarian move, acquiring 374,500 shares at $2.66 for $997,219—his largest purchase in months. As a business development company focused on middle-market lending, Prospect benefits from higher rates on new originations while today's economic data suggests credit demand remains robust.

With PSEC yielding over 10%, John's purchase signals confidence that the dividend remains sustainable despite market fears about BDC credit quality. The timing suggests he views current valuations as divorced from underlying business fundamentals.

Biotech Coordinated Accumulation Continues

Building on yesterday's $3.4 million biotech surge, Absci Corp (ABSI) leadership extended their buying spree with Director Menelas Pangalos adding 95,785 shares ($254,788) and CAO Todd Bedrick purchasing 10,000 shares ($27,000). The AI-driven protein engineering company represents exactly the type of growth-at-reasonable-price opportunity insiders are targeting as tech valuations reset.

Jasper Therapeutics (JSPR) witnessed unprecedented board coordination with four directors simultaneously purchasing shares at $2.43: CEO Ron Martell and Director Judith Shizuru each bought 41,000 shares ($99,630), Director Thomas Wiggans matched their purchases, and Director Svetlana Lucas added 20,000 shares ($48,600). This level of synchronized buying typically signals either major positive developments or extreme value recognition.

Private Equity Navigator Fund Entry Signal

Adams Street Private Equity Navigator Fund CEO James Walker initiated a position with 23,428 shares ($249,977) at $10.67, marking his first documented purchase. As private equity deal flow accelerates amid market volatility, Walker's timing suggests he expects significant fund appreciation as distressed opportunities multiply.

Forward Looking: Rate-Sensitive Sectors at Inflection Point

Tonight's Costco earnings will test whether consumer strength matches today's housing resilience, while tomorrow's September PMI data could determine if today's insider bets prove prescient. The coordinated real estate finance buying, combined with biotech accumulation, suggests sophisticated investors expect:

  1. Fed pause approaching as economic data shows resilience without overheating
  2. Value rotation accelerating as growth stock valuations compress
  3. Credit cycle bottoming in specialty finance and BDC sectors

With $3.2 million in cross-sector insider deployment this week concentrated in beaten-down value plays, the message is clear: while headline markets struggle for direction, opportunistic capital is aggressively positioning for the next cycle. Today's housing surprise provides the fundamental backdrop these insiders were anticipating.

Referenced Insider Trades

ARVN
Arvinas, Inc.

Morrison Briggs (Dir)

$227,010
30,000 shares @ $7.57
Trade Date: 9/22/2025 | Filed: 9/24/2025
ADMQ
Adm Endeavors, Inc.

Johnson Marc (CEO)

$109,950
467,000 shares @ $0.24
Trade Date: 9/19/2025 | Filed: 9/24/2025
ABSI
Absci Corp

Pangalos Menelas N (Dir)

$254,788
95,785 shares @ $2.66
Trade Date: 9/22/2025 | Filed: 9/24/2025
ABSI
Absci Corp

Bedrick Todd (SVP, CAO)

$27,000
10,000 shares @ $2.7
Trade Date: 9/22/2025 | Filed: 9/24/2025
PSEC
Prospect Capital Corp

Barry John F (CEO, 10%)

$997,219
374,500 shares @ $2.66
Trade Date: 9/22/2025 | Filed: 9/24/2025
JSPR
Jasper Therapeutics, Inc.

Wiggans Thomas G (Dir)

$99,630
41,000 shares @ $2.43
Trade Date: 9/22/2025 | Filed: 9/24/2025
JSPR
Jasper Therapeutics, Inc.

Lucas Svetlana (Dir)

$48,600
20,000 shares @ $2.43
Trade Date: 9/22/2025 | Filed: 9/24/2025
JSPR
Jasper Therapeutics, Inc.

Martell Ron (Pres, CEO)

$99,630
41,000 shares @ $2.43
Trade Date: 9/22/2025 | Filed: 9/24/2025
JSPR
Jasper Therapeutics, Inc.

Shizuru Judith Anne (Dir)

$99,630
41,000 shares @ $2.43
Trade Date: 9/22/2025 | Filed: 9/24/2025
MSIF
Msc Income Fund, Inc.

Niemann John O. Jr. (Dir)

$27,500
2,000 shares @ $13.75
Trade Date: 9/23/2025 | Filed: 9/24/2025
PMT
Pennymac Mortgage Investment Trust

Lynch Catherine A. (Dir)

$33,932
2,823 shares @ $12.02
Trade Date: 9/22/2025 | Filed: 9/24/2025
NREF
Nexpoint Real Estate Finance, Inc.

Dondero James D (Pres, 10%)

$945,780
66,000 shares @ $14.33
Trade Date: 9/22/2025 | Filed: 9/24/2025
ASPJX
Adams Street Private Equity Navigator Fund LLC

Walker James Francis (Pres, CEO)

$249,977
23,428 shares @ $10.67
Trade Date: 9/24/2025 | Filed: 9/24/2025

Sources